Introduction
China Pharmacology Bulletin (English version), also known as Pharmacology and Clinics of Chinese Materia Medica, is a peer-reviewed academic journal that was first published in 1985. The journal is bi-monthly. It covers different aspects of pharmacology, including the study of drugs and their effects, clinical trials, pharmacokinetics, and toxicology. In particular, the journal focuses on traditional Chinese medicines and their clinical applications.
Impact Factor
The impact factor of a journal reflects its importance and popularity among researchers. The impact factor is calculated by dividing the number of citations received by the articles published in the journal in the last two years by the total number of articles published in the same period. The higher the impact factor, the more likely the journal is to be read and cited by other researchers in the field.
According to the Journal Citation Reports (JCR) for 2020, the impact factor of China Pharmacology Bulletin (English version) is 1.149. This reflects a slight increase from the 2019 impact factor of 1.079. It is worth noting that the impact factor of the journal has been steadily increasing over the past few years, from a low of 0.607 in 2010 to its current level.
Comparison with Other Journals
When comparing the impact factor of China Pharmacology Bulletin (English version) with other journals in the field of pharmacology, it is important to consider the scope and focus of each journal. Some journals may specialize in a narrow area of research, while others may have a broader focus.
According to the JCR for 2020, the impact factor of Chinese Journal of Pharmacology and Toxicology, another major pharmacology journal in China, is 1.303, which is somewhat higher than China Pharmacology Bulletin (English version). However, this journal has a focus on toxicology not shared by China Pharmacology Bulletin (English version). Other pharmacology journals with higher impact factors than China Pharmacology Bulletin (English version) include Cell, Nature Reviews Drug Discovery, and Pharmacological Reviews, which have impact factors of 36.216, 48.642, and 18.849, respectively. However, these journals have a much broader scope and focus than China Pharmacology Bulletin (English version).
Conclusion
China Pharmacology Bulletin (English version) is an important journal in the field of pharmacology, particularly for researchers interested in traditional Chinese medicines and their clinical applications. The impact factor of the journal has been steadily increasing over the past few years, reflecting its growing popularity and influence among researchers. While the impact factor of the journal is lower than some other pharmacology journals, it is important to consider the scope and focus of each journal when making comparisons. Overall, China Pharmacology Bulletin (English version) is a valuable resource for researchers in the field of pharmacology, and its impact factor reflects its growing importance and influence.
